Yousif Capital Management LLC Sells 2,994 Shares of Envista Holdings Co. (NYSE:NVST)

Yousif Capital Management LLC reduced its stake in Envista Holdings Co. (NYSE:NVST) by 4.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 62,315 shares of the company’s stock after selling 2,994 shares during the period. Yousif Capital Management LLC’s holdings in Envista were worth $1,202,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Nuance Investments LLC boosted its position in shares of Envista by 4.4% during the 3rd quarter. Nuance Investments LLC now owns 7,346,534 shares of the company’s stock worth $145,168,000 after acquiring an additional 308,221 shares in the last quarter. Clarkston Capital Partners LLC boosted its holdings in shares of Envista by 0.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 4,347,300 shares of the company’s stock valued at $85,903,000 after purchasing an additional 17,085 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Envista by 26.5% in the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock worth $78,480,000 after acquiring an additional 830,861 shares during the last quarter. Pacer Advisors Inc. boosted its stake in shares of Envista by 22.2% in the 3rd quarter. Pacer Advisors Inc. now owns 3,529,827 shares of the company’s stock valued at $69,749,000 after purchasing an additional 642,401 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Envista by 2.5% during the 3rd quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock valued at $57,233,000 after purchasing an additional 71,435 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on NVST. Wells Fargo & Company increased their price objective on shares of Envista from $20.00 to $21.00 and gave the company an “equal weight” rating in a research note on Thursday, February 6th. Stifel Nicolaus lifted their price target on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Piper Sandler increased their price objective on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 3rd. Jefferies Financial Group boosted their price target on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Mizuho initiated coverage on Envista in a report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 target price for the company. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $20.21.

Envista Stock Performance

NYSE NVST opened at $21.49 on Friday. The company has a current ratio of 2.04, a quick ratio of 1.77 and a debt-to-equity ratio of 0.44. The company has a fifty day simple moving average of $19.90 and a 200 day simple moving average of $19.28. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $23.06. The company has a market cap of $3.70 billion, a P/E ratio of -3.31, a PEG ratio of 2.06 and a beta of 1.34.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Sell-side analysts predict that Envista Holdings Co. will post 1.06 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.